These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2024959)

  • 1. In vitro activity and beta-lactamase stability of GR69153, a new long-acting cephalosporin.
    Chin NX; Gu JW; Fang W; Neu HC
    Antimicrob Agents Chemother; 1991 Feb; 35(2):259-66. PubMed ID: 2024959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of Ro 09-1428 compared to other cephalosporins.
    Chin NX; Gu JW; Fang W; Neu HC
    Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):669-75. PubMed ID: 1748124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity and beta-lactamase stability of LJC 10,627.
    Neu HC; Gu JW; Fang W; Chin NX
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1418-23. PubMed ID: 1510436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of cefquinome, a new cephalosporin, compared with other cephalosporin antibiotics.
    Chin NX; Gu JW; Fang W; Neu HC
    Diagn Microbiol Infect Dis; 1992; 15(4):331-7. PubMed ID: 1611848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of a catechol-substituted cephalosporin, GR69153.
    Wise R; Andrews JM; Ashby JP; Thornber D
    Antimicrob Agents Chemother; 1991 Feb; 35(2):329-34. PubMed ID: 2024966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of GR69153, a novel catechol-substituted cephalosporin.
    Erwin ME; Jones RN; Barrett MS; Briggs BM; Johnson DM
    Antimicrob Agents Chemother; 1991 May; 35(5):929-37. PubMed ID: 1854174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of a new cephalosporin ME-1206 compared with other agents.
    Chin NX; Zhang YX; Neu HC
    Diagn Microbiol Infect Dis; 1991; 14(5):417-24. PubMed ID: 1797456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporin.
    Neu HC; Chin NX; Huang HB
    Antimicrob Agents Chemother; 1993 Mar; 37(3):566-73. PubMed ID: 8460925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
    Nishino T; Otsuki M; Hatano K; Nishihara Y
    Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporin.
    Neu HC; Saha G; Chin NX
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1795-800. PubMed ID: 2589845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
    Neu HC; Chin NX; Neu NM
    Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of ME1228, a new parenteral cephalosporin.
    Neu HC; Saha G; Chin NX
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1260-7. PubMed ID: 2802554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.
    Martínez-Beltrán J; Cantón R; Liñares J; García de Lomas J; Gimeno C; Tubau F; Baquero F
    Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):244-52. PubMed ID: 7614970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo activities of LB10522, a new catecholic cephalosporin.
    Kim MY; Oh JI; Paek KS; Kim YZ; Kim IC; Kwak JH
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1825-31. PubMed ID: 8843288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolates.
    Washington JA; Jones RN; Allen SD; Gerlach EH; Koontz FP; Murray PR; Pfaller MA; Erwin ME
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1508-11. PubMed ID: 1929319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2003 Oct; 56(5):458-96. PubMed ID: 14692381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity and beta-lactamase stability of RU29246, the active metabolite of HR916B.
    Yu KW; Chin NX; Neu HC
    Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):652-9. PubMed ID: 1396779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibacterial activities of FK037: a new parenteral cephalosporin.
    Inoue K; Inoue E; Mitsuhashi S
    Chemotherapy; 1995; 41(4):257-66. PubMed ID: 7555206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of the novel cephalosporin GR69153.
    Clarke AM; Zemcov SJ
    Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):683-7. PubMed ID: 1748126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.